Журнал «Почки» Том 14, №2, 2025

У статті наведено аналіз теоретичних та практичних результатів досліджень у базах даних PubMed, MedLine, Embase, Scopus та Web of Science щодо вивчення проблеми метаболізму вітаміну D і його ролі у розвитку мінеральних та кісткових розладів у дітей із наявною хронічною хворобою нирок, оцінки потенційних нутритивних потреб та факторів ризику розвитку ускладнень мінерального та кісткового обмінів на тлі нефрологічної патології. У статті приділяється увага питанням застосування вітаміну D при нирковозамісній терапії у пацієнтів дитячого віку.

The article presents an analysis of theoretical and practical results of research in PubMed, MEDLINE, Embase, Scopus and Web of Science databases on the study of vitamin D metabolism and its role in the development of mineral and bone disorders in children with chronic kidney disease, assessment of potential nutritional needs and risk factors for the development of complications of mineral and bone metabolism on the background of nephrological pathology. The article focuses on the use of vitamin D in renal replacement therapy in pediatric patients.

вітамін D; діти; хронічна хвороба нирок; хронічна хвороба нирок — мінеральні та кісткові розлади; замісна ниркова терапія; огляд

vitamin D; children; chronic kidney disease; chronic kidney disease — mineral and bone disorder; renal replacement therapy; review

1. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017 Jun;18(2):153-165. doi: 10.1007/s11154-017-9424-1.
2. Tice JA, Halalau A, Burke H. Vitamin D Does Not Prevent Cancer or Cardiovascular Disease: The VITAL Trial: Manson JE, Cook NR, Lee IM, et al. (2019). Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 380(1):33-44. J Gen Intern Med. 2020 Aug 12. doi: 10.1007/s11606-020-05648-x.
3. Fiamenghi VI, Mello ED. Vitamin D deficiency in children and adolescents with obesity: a meta-analysis. J Pediatr (Rio J). 2021 May-Jun;97(3):273-279. doi: 10.1016/j.jped.2020.08.006.
4. Oktaria V, Triasih R, Graham SM, Bines JE, Soenarto Y, Clarke MW, et al. Vitamin D deficiency and severity of pneumonia in Indonesian children. PLoS One. 2021 Jul 9;16(7):e0254488. doi: 10.1371/journal.pone.0254488.
5. He LP, Song YX, Zhu T, Gu W, Liu CW. Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children. J Diabetes Res. 2022 Sep 2;2022:5953562. doi: 10.1155/2022/5953562.
6. Konuksever D, Yücel Karakaya SP, Bölük O, Koçak M, Kılıç BO, Saç RÜ. The association of vitamin D deficiency with hemogram-derived inflammatory biomarkers in children. Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2418-2423. doi: 10.1016/j.numecd.2022.07.012.
7. Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023 Jan 30;15(3):695. doi: 10.3390/nu15030695.
8. Johnson CR, Thacher TD. Vitamin D: immune function, inflammation, infections and auto-immunity. Paediatr Int Child Health. 2023 Nov;43(4):29-39. doi: 10.1080/20469047.2023.2171759.
9. Liu Z, Huang S, Yuan X, Wang Y, Liu Y, Zhou J. The role of vitamin D deficiency in the development of paediatric diseases. Ann Med. 2023 Dec;55(1):127-135. doi: 10.1080/07853890.2022.2154381.
10. Alenazi KA, Alanezi AA. Prevalence of Vitamin D Deficiency in Children With Cerebral Palsy: A Meta-Analysis. Pediatr Neurol. 2024 Oct;159:56-61. doi: 10.1016/j.pediatrneurol.2024.03.021.
11. Bahardoust M, Salari S, Ghotbi N, Rahimpour E, Haghmoradi M, Alipour H, Soleimani M. Association between prenatal vitamin D deficiency with dental caries in infants and children: a syste–matic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Apr 8;24(1):256. doi: 10.1186/s12884-024-06477-0.
12. Jørgensen HS, Vervloet M, Cavalier E, Bacchetta J, de Borst MH, Bover J, et al. The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement. Nephrol Dial Transplant. 2025 Apr 1;40(4):797-822. doi: 10.1093/ndt/gfae293.
13. Rykova OV, Zaft VB, Zaft AA, Klimova GO, Boyko IV, Galitskay VV. Problem of vitamin D deficiency. RE [Internet]. 2015 Apr. 14 [cited 2025 Apr. 11];(22):93-6. Available from: https://reproduct-endo.com/article/view/46942.
14. Kaminsky O. Vitamin D dosage. International journal of endocrinology (Ukraine) [Internet]. 2021 Sep. 27 [cited 2025 Apr. 11];17(5):435-42. Available from: https://iej.zaslavsky.com.ua/index.php/journal/article/view/1092. 
15. Dedukh NV, Grygorieva NV. The role of vitamin d in the functioning of bone cells. Fiziol. Zh. 2023;69(6):108-119. doi: https://doi.org/10.15407/fz69.06.108.
16. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016 Jan;96(1):365-408. doi: 10.1152/physrev.00014.2015.
17. Yamada S, Nakano T. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. J Atheroscler Thromb. 2023 Aug 1;30(8):835-850. doi: 10.5551/jat.RV22006.
18. Bouillon R, Bikle D. Vitamin D Metabolism Revised: Fall of Dogmas. J Bone Miner Res. 2019 Nov;34(11):1985-1992. doi: 10.1002/jbmr.3884.
19. Pike JW, Meyer MB. The unsettled science of nonrenal calcitriol production and its clinical relevance. J Clin Invest. 2020 Sep 1;130(9):4519-4521. doi: 10.1172/JCI141334.
20. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
21. Jean G, Souberbielle JC, Chazot C. Vitamin D in Chro–nic Kidney Disease and Dialysis Patients. Nutrients. 2017 Mar 25;9(4):328. doi: 10.3390/nu9040328.
22. Banerjee S, Basu S, Sen A, Sengupta J. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2017 Nov;32(11):2063-2070. doi: 10.1007/s00467-017-3716-2. 
23. Villafuerte-Ledesma HM, Moragrega B, Castillón E, Luzón-Alonso M, García-Mena M. Association between vitamin D serum levels and inflammatory markers in patients on hemodialysis. Gac Med Mex. 2020;156(6):509-515. English. doi: 10.24875/GMM.M21000452.
24. Matsumoto AK, Maes M, Michelin AP, Soares AE, Semeão LO, Godeny P, et al. Vitamin D deficiency is not associated with increased oxidative stress in chronic kidney disease pre-dialysis patients. J Bras Nefrol. 2020 Oct-Dec;42(4):420-428. doi: 10.1590/2175-8239-JBN-2019-0156.
25. Banerjee S, Basu S, Akhtar S, Sinha R, Sen A, Sengupta J. Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls. Pediatr Nephrol. 2020 Mar;35(3):447-454. doi: 10.1007/s00467-019-04433-1.
26. Maji M, Kumar M, Chacham S, Mirza AA, Bhat NK, Mandal S. Severity of Vitamin D Deficiency in Children with Nephrotic Syndrome: A Study from Tertiary Care Center in Northern India. Saudi J Kidney Dis Transpl. 2022 Sep 1;33(5):608-616. doi: 10.4103/1319-2442.389421.
27. Visiedo L, Pérez Abud R, Rivas-Ruiz F, Payan JJ, Rey L, Tortajada B, Abilés J. Hypovitaminosis D and its relationship with nutritional status and quality of life in patients undergoing haemodialysis. Nutr Hosp. 2023 Feb 15;40(1):144-150. English. doi: 10.20960/nh.04150.
28. Hsu S, Zelnick LR, Lin YS, Best CM, Kestenbaum B, Thummel KE, et al. Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study. J Am Soc Nephrol. 2021 Jan;32(1):188-198. doi: 10.1681/ASN.2020050625.
29. Ginsberg C, Hoofnagle AN, Katz R, Becker JO, Kritchevsky SB, Shlipak MG, et al. The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration. Clin Chem. 2021 Jan 30;67(2):385-393. doi: 10.1093/clinchem/hvaa238.
30. Hsu S, Zelnick LR, Lin YS, Best CM, Kestenbaum BR, Thummel KE, et al. Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance. J Steroid Biochem Mol Biol. 2022 Mar;217:106047. doi: 10.1016/j.jsbmb.2021.106047.
31. Ishimine N, Wu S, Ota R, Takahashi K, Takiwaki M, Sugano M, et al. Development of free 25-hydroxyvitamin D3 assay method using liquid chromatography-tandem mass spectrometry. Biosci Rep. 2022 Oct 28;42(10):BSR20221326. doi: 10.1042/BSR20221326.
32. Lee S, Chung HJ, Jung S, Jang HN, Chang SH, Kim HJ, Cho MC. 24,25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease. Nutrients. 2023 Jan 22;15(3):578. doi: 10.3390/nu15030578.
33. Hsu S, Zelnick LR, Bansal N, Brown J, Denburg M, Feldman HI, et al.; CRIC Study Investigators. Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2023 Jul 18;12(14):e028561. doi: 10.1161/JAHA.122.028561.
34. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol. 2012 Feb;7(2):216-23. doi: 10.2215/CJN.04760511.
35. Gravesen E, Hofman-Bang J, Lewin E, Olgaard K. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5. Scand J Clin Lab Invest. 2013 Mar;73(2):107-16. doi: 10.3109/00365513.2012.744464.
36. Dreyer G, Tucker AT, Harwood SM, Pearse RM, Raftery MJ, Yaqoob MM. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin D deficiency: an exploratory, double blind, randomised controlled trial. PLoS One. 2014 Jul 9;9(7):e99461. doi: 10.1371/journal.pone.0099461.
37. Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015 Apr 7;10(4):611-9. doi: 10.2215/CJN.06910714.
38. Wetmore JB, Kimber C, Mahnken JD, Stubbs JR. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Br J Nutr. 2016 Dec;116(12):2074-2081. doi: 10.1017/S000711451600427X.
39. Zhang D, Li H, Yin D, Wang L, Ma Y. Ergocalciferol versus calcitriol for controlling chronic kidney disease mineral bone disorder in stage 3 to 5 CKD: A randomized controlled trial. Eur J Pharmacol. 2016 Oct 15;789:127-133. doi: 10.1016/j.ejphar.2016.07.019.
40. Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, et al. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016;44(4):316-325. doi: 10.1159/000450766.
41. Batacchi Z, Robinson-Cohen C, Hoofnagle AN, Isakova T, Kestenbaum B, Martin KJ, et al. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1498-1506. doi: 10.2215/CJN.00530117.
42. Strugnell SA, Csomor P, Ashfaq A, Bishop CW. Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease. Kidney Dis (Basel). 2023 Feb 10;9(3):206-217. doi: 10.1159/000529523.
43. Bezruk V, Andriychuk T, Ivanov D, Fomina S, Shkrobanets І. Standardization of medical care provision to children: local clinical protocol of medical care for children with glomerulonephritis at the level of the hospital district. Kidneys [Internet]. 2024 Mar. 14 [cited 2025 Apr. 13];13(1):2-17. Available from: https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/436.
44. Christodoulou M, Aspray TJ, Schoenmakers I. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. Calcif Tissue Int. 2021 Aug;109(2):157-178. doi: 10.1007/s00223-021-00844-1.
45. Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, et al.; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups. Clinical practice recommendations for native vitamin D the–rapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant. 2017 Jul 1;32(7):1098-1113. doi: 10.1093/ndt/gfx065.
46. Magagnoli L, Cassia M, Galassi A, Ciceri P, Massó E, Gelpi R et al. Vitamin D: are all compounds equal? Clin Kidney J. 2025 Mar 13;18(Suppl 1):i61-i96. doi: 10.1093/ckj/sfae417.
47. Torregrosa JV, Bover J, Rodríguez Portillo M, González Parra E, Dolores Arenas M, Caravaca F, et al. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM). Nefrologia (Engl Ed). 2023 Jun;43 Suppl 1:1-36. doi: 10.1016/j.nefroe.2023.03.003.
48. Frazão JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, et al. Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis. 2000 Sep;36(3):550-61. doi: 10.1053/ajkd.2000.16193.
49. Dennis VC, Albertson GL. Doxercalciferol treatment of secondary hyperparathyroidism. Ann Pharmacother. 2006 Nov;40(11):1955-65. doi: 10.1345/aph.1G523.
50. Gozhenko A, Ivanov D. What can a tandem of a pathophysiologist and a clinician bring to clinical practice? Kidneys [Internet]. 2024 Jun. 16 [cited 2025 Apr. 15];13(2):96-100. Available from: https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/451.